| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 25.32 mm | 25.32 mm | 25.32 mm | 25.32 mm | 25.32 mm | 25.32 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 4.02 mm | 5.83 mm | 4.51 mm | 4.26 mm |
| Cash used (since last report) | n/a | n/a | 21.38 mm | 31.01 mm | 24.00 mm | 22.62 mm |
| Cash remaining | n/a | n/a | 3.94 mm | -5.69 mm | 1.32 mm | 2.70 mm |
| Runway (months of cash) | n/a | n/a | 1.0 | -1.0 | 0.3 | 0.6 |
| 13F holders | Current |
|---|---|
| Total holders | 52 |
| Opened positions | 6 |
| Closed positions | 7 |
| Increased positions | 13 |
| Reduced positions | 11 |
| 13F shares | Current |
|---|---|
| Total value | 30.33 bn |
| Total shares | 40.76 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Viking Global Investors | 4.19 mm | $4.03 bn |
| JNJ Johnson & Johnson | 3.64 mm | $3.49 bn |
| 5AM Venture Management | 3.63 mm | $3.49 bn |
| New Leaf Venture Partners, L.L.C. | 3.30 mm | $3.17 bn |
| TPG GP A | 3.03 mm | $2.91 bn |
| 5AM Ventures V | 2.48 mm | $22.96 mm |
| Pivotal bioVenture Partners Fund I | 2.40 mm | $3.99 mm |
| Pivotal bioVenture Partners Investment Advisor | 2.40 mm | $2.31 bn |
| New Leaf Ventures III | 2.15 mm | $0.00 |
| Canaan XI | 2.06 mm | $2.72 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Feb 25 | Lieber Jonathan I | Option Common Stock | Grant | Acquire A | No | No | 0.76 | 180,000 | 136.80 k | 180,000 |
| 14 Feb 25 | Steven Ryder | Option Common Stock | Grant | Acquire A | No | No | 0.76 | 180,000 | 136.80 k | 180,000 |
| 14 Feb 25 | Stephen Uden | Option Common Stock | Grant | Acquire A | No | No | 0.76 | 453,700 | 344.81 k | 453,700 |
| 2 Jan 25 | Robert Lorne Hopfner | Option Common Stock | Grant | Acquire A | No | No | 0.7 | 73,571 | 51.50 k | 73,571 |
| 2 Jan 25 | Hunt Ronald | Option Common Stock | Grant | Acquire A | No | No | 0.7 | 73,571 | 51.50 k | 73,571 |
